July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Utilizing CRISPR to perturb photoreceptor/bipolar enhancer mediated cell fate decisions in the mouse retina
Author Affiliations & Notes
  • Noah Goodson
    Ophthalmology, University of Colorado Denver, Aurora, Colorado, United States
    Neuroscience Program, University of Colorado Denver, Aurora, Colorado, United States
  • Joseph A Brzezinski
    Ophthalmology, University of Colorado Denver, Aurora, Colorado, United States
  • Footnotes
    Commercial Relationships   Noah Goodson, None; Joseph Brzezinski, None
  • Footnotes
    Support  TL1 TR002533, R01-EY024272
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6043. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Noah Goodson, Joseph A Brzezinski; Utilizing CRISPR to perturb photoreceptor/bipolar enhancer mediated cell fate decisions in the mouse retina. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6043. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The mechanisms that set the numbers of photoreceptors and bipolar cell interneurons formed during development are poorly understood. Two transcription factors, Prdm1 and Vsx2, influence rod photoreceptor and bipolar cell fate decisions late in retinal development. Disruption of either factor changes the number of rods and bipolars formed. We tested the hypothesis that these transcription factors do not instruct fate choice directly, but instead work in a mutually inhibitory gene regulatory network to establish the proportion of rods and bipolars.

Methods : We probed how the Prdm1 and Vsx2 gene regulatory network affects fate choice by taking a CRISPR/Cas9 approach to perturb these genes individually and simultaneously. To minimize effects on retinal progenitor cells, we targeted key enhancers for Prdm1 and Vsx2. This was done by in vivo electroporation of mouse retinas at postnatal day (P) 0. We quantitatively examined cell fate at P4, P7, P14, and P28 (N=6 mice/condition) by immunohistochemistry.

Results : CRISPR/Cas9 targeting of the Prdm1 and Vsx2 enhancers resulted in a strong decrease in the number of cells that expressed PRDM1 and VSX2 proteins in the retina. Perturbing Prdm1 or Vsx2 singly significantly (unpaired t-tests, P<0.001) altered the rod to bipolar ratio we observed. Conversely, simultaneous deletion of the Prdm1 and Vsx2 enhancers resulted in a rod to bipolar cell ratio that was similar to non-targeting control electroporated cells.

Conclusions : Our findings show that targeting key enhancers with CRISPR/Cas9 can be used to precisely perturb gene function singly or in combination. Our results suggest that Prdm1 and Vsx2 work in a mutually inhibitory network to set the numbers of rods and bipolar cells formed. While Vsx2 and Prdm1 regulate numbers, they are not necessary for photoreceptor or bipolar cell fate specification or formation. Future work will focus on uncovering the instructive factors driving rod and bipolar fate specification.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×